Chromatin accessibility changes at intergenic regions associates with ovarian cancer drug resistance
J. Gallon, E. Loomis, E. Curry, N. Martin, L. Brody, I. Garner, R. Brown, J. M. Flanagan
The paper examines chromatin accessibility changes in ovarian cancer cell lines resistant to platinum-based chemotherapy, finding intergenic region alterations linked to drug resistance and Pt-adduct distribution.
bioRxiv · Feb 24, 2021Cancer Biology